Pharmamarketeer

NIH to conduct large trial for COVID-19 polyclonal antibody therapies

COVID-19

The National Institutes of Health (NIH) in the USA are to conduct a large-scale clinical trial to evaluate a new fully-human polyclonal antibody therapy targeted at severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of coronavirus disease 2019 (COVID-19).

Advertentie(s)